Abstract:Oncogene induced senescence is a tumor suppressing defense mechanism, in which the cell cycle-dependent protein kinase (CDK) inhibitor p16INK4A (encoded by the CDKN2A gene) plays a key role. We previously reported that a transcriptional co-activator chromodomain helicase DNA binding protein 7 (CHD7) mediates oncogenic ras-induced senescence by inducing transcription of the p16INK4A gene. In the current study, we identified myeloid zinc finger 1 (MZF1) as the transcriptional factor that recruits CHD7 to the p16INK4A promoter, where it mediates oncogenic ras-induced p16INK4A transcription and senescence through CHD7, in primary human cells from multiple origins. Moreover, the expression of MZF1 is induced by oncogenic ras in senescent cells through the c-Jun and Ets1 transcriptional factors upon their activation by the Ras-Raf-1-MEK-ERK signaling pathway. In non-small cell lung cancer (NSCLC) and pancreatic adenocarcinoma (PAAD) where activating ras mutations occur frequently, reduced MZF1 expression is observed in tumors, as compared to corresponding normal tissues, and correlates with poor patient survival. Analysis of single cell RNA-sequencing data from PAAD patients revealed that among the tumor cells with normal RB expression levels, those with reduced levels of MZF1 are more likely to express lower p16INK4A levels. These findings have identified novel signaling components in the pathway that mediates induction of the p16INK4A tumor suppressor and the senescence response, and suggested that MZF1 is a potential tumor suppressor in at least some cancer types, the loss of which contributes to the inactivation of the p16INK4A/RB pathway and disruption of senescence in tumor cells with intact RB.

Transcriptional factor HBP1 targets P16 INK4A , upregulating its expression and consequently is involved in Ras-induced premature senescence

The HBP1 transcriptional repressor participates in RAS-induced premature senescence.

HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence.

HBP1-mediated Regulation of P21 Protein Through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis

Tumor Suppressor Gene Insulin-Like Growth Factor Binding Protein-Related Protein 1 (Igfbp-Rp1) Induces Senescence-Like Growth Arrest in Colorectal Cancer Cells

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A

PIM1-catalyzed CBX8 Phosphorylation Promotes the Oncogene-Induced Senescence of Human Diploid Fibroblast.

The HBP1 Transcriptional Repressor and the P38 MAP Kinase: Unlikely Partners in G1 Regulation and Tumor Suppression

Regulation of Cellular Senescence and p16INK4a Expression by Id1 and E47 Proteins in Human Diploid Fibroblast

The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways

A Positive Feedback Loop Between Pim-1 Kinase and HBP1 Transcription Factor Contributes to Hydrogen Peroxide-Induced Premature Senescence and Apoptosis

The Tumor Suppressor P33ing1b Upregulates P16ink4a Expression and Induces Cellular Senescence

The Acetylation of Transcription Factor HBP1 by P300/cbp Enhances P16ink4a Expression

Protein kinase D1 phosphorylates CBX8 to facilitate the disassociation of PRC1 complex from p16 promoter and promotes cell senescence

B-MYB Delays Cell Aging by Repressing P16 INK4α Transcription

Cell Senescence and Transcriptional Regulation of P16ink4a

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence

P16INK4A drives RB1 degradation by UTP14A-catalyzed K810 ubiquitination